Bahareh Rajaei

After my B.Sc. and M.Ss. in Microbiology, my interest in stem cell biology and tissue engineering led me further to work on pluripotent stem cell, beta cell differentiation and developing a stem cell therapy. In 2011, I started my Ph.D in Medical Biotechnology at “National Institute of Genetic Engineering and Biotechnology (NIGEB)” in Iran. As a PhD project, I worked on the generation of the induced Pluripotent Stem (iPS) cells derived from Type 1 Diabetic (T1D) patients and guided differentiation toward pancreatic beta cells in the lab of Dr. Mohammad Massumi.
In 2018, I continued my research as a PostDoctoral fellow at the “ULB Center for Diabetes Research” in Belgium. During my fellowship, my main focus was evaluating the effect of GLP1 analogs for the treatment of Wolfram syndrome on the iPSC-derived beta cells and CRISPR-CAS9 isogenic corrected iPS cells as cellular models. This project was under supervision of Prof. Mariana Igoillo Esteve.

In 2019, I joined the group of Prof. Eelco de Koning and Dr. Françoise Carlotti as a PostDoc, where my focus is the regenerative medicine for diabetes by producing insulin-producing cells from human pluripotent stem cells using GMP-compliant processes for translation to the clinic. This is part of the diabetes project in the Dutch consortium for regenerative medicine RegMedXB

Follow me on LinkedIn
ResearchGate